|
Drug Discovery: a new therapeutic class of small molecules for Analgesia
Pharmaleads main and most advanced drug discovery program is in the field of Analgesia, with an innovative family of compounds: dual inhibitors of NEP and APN. The lead compound of this family belongs to a new therapeutic class of small molecules
Reagents: very specific substrates
Pharmaleads has developed two lines of products in the field of Reagent:
Pharmaleads can also provide you with customized substrates for any given Proteases through a services agreement.
|
